General Information of Drug (ID: DMEMZ6Q)

Drug Name
BRL-55473 Drug Info
Synonyms CHEMBL336590; SCHEMBL3133982; SCHEMBL3133975; SCHEMBL12390534; BRL-57269A; BDBM50212570
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
9816018
TTD Drug ID
DMEMZ6Q

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ACECLIDINE DMOLNCZ Glaucoma/ocular hypertension 9C61 Approved [2]
Methacholine Chloride DMGS4QH Asthma CA23 Approved [3]
Tropicamide DM1D90W Mydriasis LA11.62 Approved [4]
Diphenidol DMHPWOM Nausea MD90 Approved [5]
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one DMM9X0G Discovery agent N.A. Investigative [6]
A-987306 DMU34BK Discovery agent N.A. Investigative [7]
ISOCLOZAPINE DM52CPU Discovery agent N.A. Investigative [8]
FLUMEZAPINE DMW0HOG Discovery agent N.A. Investigative [9]
ISOLOXAPINE DMH1BN4 Discovery agent N.A. Investigative [10]
Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester DMVEH40 Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ACECLIDINE DMOLNCZ Glaucoma/ocular hypertension 9C61 Approved [2]
Fesoterodine fumarate DM13495 Overactive bladder GC50.0 Approved [11]
SMT-D002 DM1I93C Seborrhea ED91.2 Approved [12]
Clidinium DMUMQZ0 Abdominal stomach pain DD91.4 Approved [13]
Trihexyphenidyl DMB19L8 Dystonia 8A02 Approved [14]
Oxyphenonium DMMQHOZ Visceral spasms MD81.4 Approved [15]
Benztropine DMGZOVN Parkinson disease 8A00.0 Approved [16]
Glycopyrrolate DM2M3ZA Anaesthesia 9A78.6 Approved [17]
Pirenzepine DMP6M1N Peptic ulcer DA61 Approved [18]
Cycrimine DM8C43Q Parkinson disease 8A00.0 Approved [19]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ACECLIDINE DMOLNCZ Glaucoma/ocular hypertension 9C61 Approved [2]
Methacholine Chloride DMGS4QH Asthma CA23 Approved [3]
SMT-D002 DM1I93C Seborrhea ED91.2 Approved [12]
Methylscopolamine DM5VWOB Peptic ulcer DA61 Approved [20]
Gallamine Triethiodide DMPO0MS Stabilize muscle contraction FB3Z Approved [21]
FP-1097 DMC1F2T Urinary incontinence MF50.2 Phase 2 [22]
PSD-506 DMT0KB1 Overactive bladder GC50.0 Discontinued in Phase 2 [23]
Otenzepad DMRXHAC Heart failure BD10-BD13 Discontinued in Phase 2 [24]
SCH-211803 DM92E0W Parkinson disease 8A00.0 Discontinued in Phase 1 [25]
Alvameline DMLN0Y5 Alzheimer disease 8A20 Terminated [26]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tolterodine DMSHPW8 Overactive bladder GC50.0 Approved [27]
ACECLIDINE DMOLNCZ Glaucoma/ocular hypertension 9C61 Approved [2]
Tiotropium DMFDC0Q Chronic obstructive pulmonary disease CA22 Approved [28]
Ipratropium DMFQ320 Obstructive lung disease CA22.Z Approved [29]
Darifenacin DMWXLYZ Overactive bladder GC50.0 Approved [30]
Methacholine Chloride DMGS4QH Asthma CA23 Approved [31]
SMT-D002 DM1I93C Seborrhea ED91.2 Approved [12]
Solifenacin DMG592Q Overactive bladder GC50.0 Approved [32]
Methylscopolamine DM5VWOB Peptic ulcer DA61 Approved [33]
Cevimeline DMWSMND Sjogren syndrome 4A43.20 Approved [34]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Promazine DMZAL7W Acute intermittent hepatic porphyria 5C58.11 Approved [35]
ACECLIDINE DMOLNCZ Glaucoma/ocular hypertension 9C61 Approved [2]
Pilocarpine DMV9ADG Glaucoma/ocular hypertension 9C61 Approved [36]
Anisodine DMNOSWU Central and peripheral nervous disease 8A04-8E7Z Approved [37]
Atropine DMEN6X7 Organophosphate poisoning NE6Z Approved [38]
Propiverine DMUWBIJ Urinary incontinence MF50.2 Approved [39]
Umeclidinium DM4E8O9 Chronic obstructive pulmonary disease CA22 Approved [40]
Cimetropium bromide DMZHPNE Gastric motility disorder DA21 Approved [41]
Butylscopolamine DMZKXB7 Dysmenorrhea GA34.3 Approved [42]
Trospium DMX6RTG Overactive bladder GC50.0 Approved [43]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Muscarinic acetylcholine receptor M1 (CHRM1) TTZ9SOR ACM1_HUMAN Inhibitor [1]
Muscarinic acetylcholine receptor M2 (CHRM2) TTYEG6Q ACM2_HUMAN Inhibitor [1]
Muscarinic acetylcholine receptor M3 (CHRM3) TTQ13Z5 ACM3_HUMAN Inhibitor [1]
Muscarinic acetylcholine receptor M4 (CHRM4) TTQ3JTF ACM4_HUMAN Inhibitor [1]
Muscarinic acetylcholine receptor M5 (CHRM5) TTH18TF ACM5_HUMAN Inhibitor [1]

References

1 A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionality, Bioorg. Med. Chem. Lett. 2(8):791-796 (1992).
2 Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists. J Med Chem. 1993 Apr 2;36(7):842-7.
3 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors. J Med Chem. 1998 Jun 4;41(12):2047-55.
4 The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 rec... Psychopharmacology (Berl). 2007 Oct;194(3):347-59.
5 Diphenidol-related diamines as novel muscarinic M4 receptor antagonists. Bioorg Med Chem Lett. 2008 May 1;18(9):2972-6.
6 Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 rec... J Med Chem. 2010 Sep 9;53(17):6386-97.
7 cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain... J Med Chem. 2008 Nov 27;51(22):7094-8.
8 Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents. J Med Chem. 1990 Feb;33(2):809-14.
9 Synthesis and pharmacological evaluation of a series of 4-piperazinylpyrazolo[3,4-b]- and -[4,3-b][1,5]benzodiazepines as potential anxiolytics. J Med Chem. 1989 Dec;32(12):2573-82.
10 Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain. J Med Chem. 1981 Sep;24(9):1021-6.
11 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
12 Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder. J Urol. 2004 Nov;172(5 Pt 1):2059-64.
13 Accidental acute clidinium toxicity. Emerg Med J. 2009 Jun;26(6):460.
14 The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic dr... Psychopharmacology (Berl). 2009 Apr;203(2):295-301.
15 Ultraviolet spectroscopic estimation of microenvironments and bitter tastes of oxyphenonium bromide in cyclodextrin solutions. J Pharm Sci. 1999 Aug;88(8):759-62.
16 Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine. Int J Pharm. 2008 Jun 5;357(1-2):55-60.
17 Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade. Clin Pharmacol Ther. 2008 May;83(5):692-701.
18 Negative crosstalk between M1 and M2 muscarinic autoreceptors involves endogenous adenosine activating A1 receptors at the rat motor endplate. Neurosci Lett. 2009 Aug 14;459(3):127-31.
19 Capillary gas chromatography of trihexyphenidyl, procyclidine and cycrimine in biological fluids. J Chromatogr. 1989 Sep 29;494:135-42.
20 Methylacridinium and its cholinergic properties. Neurotox Res. 2009 Nov;16(4):372-7.
21 Cholinergic regulation of the corpora allata in adult male loreyi leafworm Mythimna loreyi. Arch Insect Biochem Physiol. 2002 Apr;49(4):215-24.
22 Clinical pipeline report, company report or official report of FemmePharma.
23 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
24 Beneficial effect of muscarinic-2 antagonist on dilated cardiomyopathy induced by autoimmune mechanism against muscarinic-2 receptor. J Cardiovasc Pharmacol. 2001 Oct;38 Suppl 1:S43-9.
25 Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists. J Med Chem. 2002 Dec 5;45(25):5415-8.
26 In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro. Psychopharmacology (Berl). 1998 Jun;137(3):233-40.
27 Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Pharmacol Exp Ther. 2004 Jun;309(3):1148-53.
28 DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6.
29 Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.Chem Immunol Allergy.2012;98:48-69.
30 M(1) and M(3) muscarinic receptors are involved in the release of urinary bladder-derived relaxant factor. Pharmacol Res. 2009 May;59(5):300-5.
31 Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. Am J Respir Cell Mol Biol. 2003 Feb;28(2):257-62.
32 Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout ... Eur J Pharmacol. 2009 Aug 1;615(1-3):201-6.
33 Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Br J Pharmacol. 1998 Nov;125(5):1088-94.
34 Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by cevimeline, an M3 muscarinic receptor ... Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G112-G123.
35 Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites. Life Sci. 1988;43(5):405-12.
36 Retinoic acid prevents virus-induced airway hyperreactivity and M2 receptor dysfunction via anti-inflammatory and antiviral effects. Am J Physiol Lung Cell Mol Physiol. 2009 Aug;297(2):L340-6.
37 Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965-81.
38 Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells. Neurotox Res. 2009 Oct;16(3):194-204.
39 Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland. Life Sci. 1999;64(25):2351-8.
40 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7354).
41 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
42 Comparison of pharmacological effects of L- and DL-n-butyl-scopolamine in rat uterus. Yao Xue Xue Bao. 1994;29(1):24-7.
43 Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.